 Schizophrenia
"Schizophrenia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior.
| Descriptor ID |
D012559
|
| MeSH Number(s) |
F03.700.750
|
| Concept/Terms |
Schizophrenia- Schizophrenia
- Schizophrenias
- Schizophrenic Disorders
- Disorder, Schizophrenic
- Disorders, Schizophrenic
- Schizophrenic Disorder
- Dementia Praecox
|
Below are MeSH descriptors whose meaning is more general than "Schizophrenia".
Below are MeSH descriptors whose meaning is more specific than "Schizophrenia".
This graph shows the total number of publications written about "Schizophrenia" by people in this website by year, and whether "Schizophrenia" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1980 | 0 | 1 | 1 | | 1982 | 2 | 1 | 3 | | 1983 | 0 | 4 | 4 | | 1984 | 1 | 1 | 2 | | 1985 | 4 | 1 | 5 | | 1986 | 2 | 2 | 4 | | 1987 | 4 | 1 | 5 | | 1988 | 5 | 0 | 5 | | 1989 | 3 | 0 | 3 | | 1990 | 5 | 0 | 5 | | 1991 | 9 | 0 | 9 | | 1992 | 4 | 2 | 6 | | 1993 | 13 | 1 | 14 | | 1994 | 7 | 2 | 9 | | 1995 | 7 | 1 | 8 | | 1996 | 15 | 3 | 18 | | 1997 | 9 | 3 | 12 | | 1998 | 4 | 0 | 4 | | 1999 | 5 | 1 | 6 | | 2000 | 5 | 1 | 6 | | 2001 | 9 | 3 | 12 | | 2002 | 5 | 1 | 6 | | 2003 | 4 | 0 | 4 | | 2004 | 10 | 1 | 11 | | 2005 | 6 | 2 | 8 | | 2006 | 8 | 1 | 9 | | 2007 | 8 | 4 | 12 | | 2008 | 11 | 2 | 13 | | 2009 | 7 | 3 | 10 | | 2010 | 8 | 2 | 10 | | 2011 | 12 | 1 | 13 | | 2012 | 16 | 1 | 17 | | 2013 | 18 | 1 | 19 | | 2014 | 16 | 1 | 17 | | 2015 | 9 | 0 | 9 | | 2016 | 6 | 2 | 8 | | 2017 | 11 | 2 | 13 | | 2018 | 10 | 1 | 11 | | 2019 | 9 | 5 | 14 | | 2020 | 8 | 0 | 8 | | 2021 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Schizophrenia" by people in Profiles.
-
Eum S, Hill SK, Alliey-Rodriguez N, Stevenson JM, Rubin LH, Lee AM, Mills LJ, Reilly JL, Lencer R, Keedy SK, Ivleva E, Keefe RSE, Pearlson GD, Clementz BA, Tamminga CA, Keshavan MS, Gershon ES, Sweeney JA, Bishop JR. Genome-wide association study accounting for anticholinergic burden to examine cognitive dysfunction in psychotic disorders. Neuropsychopharmacology. 2021 09; 46(10):1802-1810.
-
Peterson RE, Bigdeli TB, Ripke S, Bacanu SA, Gejman PV, Levinson DF, Li QS, Rujescu D, Rietschel M, Weinberger DR, Straub RE, Walters JTR, Owen MJ, O'Donovan MC, Mowry BJ, Ophoff RA, Andreassen OA, Esko T, Petryshen TL, Kendler KS. Genome-wide analyses of smoking behaviors in schizophrenia: Findings from the Psychiatric Genomics Consortium. J Psychiatr Res. 2021 05; 137:215-224.
-
Webber HE, Lopez-Gamundi P, Stamatovich SN, de Wit H, Wardle MC. Using pharmacological manipulations to study the role of dopamine in human reward functioning: A review of studies in healthy adults. Neurosci Biobehav Rev. 2021 01; 120:123-158.
-
Tamminga CA, Clementz BA, Pearlson G, Keshavan M, Gershon ES, Ivleva EI, McDowell J, Meda SA, Keedy S, Calhoun VD, Lizano P, Bishop JR, Hudgens-Haney M, Alliey-Rodriguez N, Asif H, Gibbons R. Biotyping in psychosis: using multiple computational approaches with one data set. Neuropsychopharmacology. 2021 01; 46(1):143-155.
-
Hochberger WC, Eskridge CLM, Bishop JR, Reilly JL, Rubin LH, Keedy S, Gershon ES, Tamminga CA, Pearlson GD, Ragozzino M, Keshavan MS, Sweeney JA, Hill SK. Catechol-O-methyltransferase genotype differentially contributes to the flexibility and stability of cognitive sets in patients with psychotic disorders and their first-degree relatives. Schizophr Res. 2020 09; 223:236-241.
-
Zhang S, Zhang H, Zhou Y, Qiao M, Zhao S, Kozlova A, Shi J, Sanders AR, Wang G, Luo K, Sengupta S, West S, Qian S, Streit M, Avramopoulos D, Cowan CA, Chen M, Pang ZP, Gejman PV, He X, Duan J. Allele-specific open chromatin in human iPSC neurons elucidates functional disease variants. Science. 2020 07 31; 369(6503):561-565.
-
Gotra MY, Hill SK, Gershon ES, Tamminga CA, Ivleva EI, Pearlson GD, Keshavan MS, Clementz BA, McDowell JE, Buckley PF, Sweeney JA, Keedy SK. Distinguishing patterns of impairment on inhibitory control and general cognitive ability among bipolar with and without psychosis, schizophrenia, and schizoaffective disorder. Schizophr Res. 2020 09; 223:148-157.
-
Anderson KM, Collins MA, Chin R, Ge T, Rosenberg MD, Holmes AJ. Transcriptional and imaging-genetic association of cortical interneurons, brain function, and schizophrenia risk. Nat Commun. 2020 06 08; 11(1):2889.
-
Clementz BA, Trotti RL, Pearlson GD, Keshavan MS, Gershon ES, Keedy SK, Ivleva EI, McDowell JE, Tamminga CA. Testing Psychosis Phenotypes From Bipolar-Schizophrenia Network for Intermediate Phenotypes for Clinical Application: Biotype Characteristics and Targets. Biol Psychiatry Cogn Neurosci Neuroimaging. 2020 08; 5(8):808-818.
-
Blackburn KM, Ivleva EI, Weir RA, Kim M, Hopkins SC, Hudgens-Haney ME, Keedy SK, Gershon ES, Sweeney JA, Keshavan MS, Pearlson GD, Clementz BA, Tamminga CA, Vernino S. NMDA receptor antibody seropositivity in psychosis: A pilot study from the Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP). Schizophr Res. 2020 04; 218:318-320.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|